Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Saroglitazar vs Fenofibrate in Dyslipidemia
NCT01539616Phase 2Completed
- Sponsor
- Zydus Lifesciences Limited
- Start
- Nov 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saroglitazar in hypertriglyceridemia, dyslipidemia, sponsored by Zydus Lifesciences Limited. Started Nov 2011; status: completed.
02
Drugs
saroglitazar
03
Conditions
hypertriglyceridemiadyslipidemia
Beyond the preview
Go deeper on NCT01539616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01539616.